Additionally, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causal agent of COVID-19, causes downregulation of angiotensin-converting enzyme 2 (ACE2), thus reducing its protective effects on various tissues. This evidence concerns the gene ACE2 and COVID-19.